晨化股份(300610.SZ):擬與上海吉碳合作對福州晨化進行增資
格隆匯6月7日丨晨化股份(300610.SZ)公佈,為進一步擴大產業佈局,加大業務領域的覆蓋範圍,公司擬與上海吉碳科技有限公司(“上海吉碳”或“乙方”)合作對晨化(福州)科技發展有限公司(“福州晨化”或“目標公司”)進行增資。增資後,福州晨化註冊資本由100萬元變更為300萬元,仍為公司控股子公司;其中公司以自有資金認繳出資180萬元,佔目標公司註冊資本的60%;上海吉碳認繳出資120萬元,佔目標公司註冊資本的40%。
公司此次對外投資可充分利用交易合作方的資源優勢,進一步拓展公司在精細化工業務領域的覆蓋範圍,推動公司產業佈局及戰略規劃的順利實施,實現合作共贏的目的。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.